4//SEC Filing
Alexander Kristen 4
Accession 0001127602-23-007933
CIK 0001062822other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:56 PM ET
Size
15.5 KB
Accession
0001127602-23-007933
Insider Transaction Report
Form 4
Alexander Kristen
VP, Finance and Accounting
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-02-28−10,617→ 21,233 total→ Common Stock (10,617 underlying) - Exercise/Conversion
Common Stock
2023-02-28+5,400→ 22,363 total - Exercise/Conversion
Common Stock
2023-02-28+2,700→ 25,063 total - Exercise/Conversion
Common Stock
2023-02-28+10,617→ 35,680 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−5,400→ 0 total→ Common Stock (5,400 underlying) - Exercise/Conversion
Restricted Stock Units
2023-02-28−2,700→ 2,700 total→ Common Stock (2,700 underlying) - Tax Payment
Common Stock
2023-02-28$2.17/sh−5,330$11,566→ 30,350 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001878867
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:56 PM ET
- Size
- 15.5 KB